ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:2253-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Micobacteriologa ( Divisão C )</b><p align=justify><strong>AMPLIFICATION, CLONING AND EXPRESSION OF A PROBABLE GMP SYNTHASE ENZYME FROM <EM>MYCOBACTERIUM TUBERCULOSIS</EM> H37RV</strong></p><p align=justify><b><u>Tathyana Mar Amorim Franco </u></b> (<i>INCT-TB PUCRS</i>); <b>Cristopher Zandoná Schneider </b> (<i>INCT-TB PUCRS</i>); <b>Luiz Augusto Basso </b> (<i>INCT-TB PUCRS</i>); <b>Diógenes Santiago Santos </b> (<i>INCT-TB PUCRS</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-ansi-language: EN-US">Tuberculosis (TB) is a serious infectious disease mainly caused by <I style="mso-bidi-font-style: normal">Mycobacterium tuberculosis</I>. Epidemiologists estimate that around one-third of the world population is latently infected with <I style="mso-bidi-font-style: normal">M. tuberculosis</I>. Since global incidence of TB has increased in recent years, there is an urgent need for developing new anti-TB drugs and vaccines. Guanosine monophosphate synthase (GMPS), is a key enzyme in the purine biosynthetic pathway, where it catalyzes the conversion of xanthosine monophosphate to guanosine monophosphate.</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-bidi-font-size: 10.0pt; mso-ansi-language: EN-US"> The <I style="mso-bidi-font-style: normal">guaA</I> (<I style="mso-bidi-font-style: normal">Rv3396c</I>) gene encoding GMPS (EC 6.3.5.2) </SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-ansi-language: EN-US">was identified by sequence homology in the</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-bidi-font-size: 10.0pt; mso-ansi-language: EN-US"> <I style="mso-bidi-font-style: normal">M. tuberculosis</I> H37Rv genome.</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-bidi-font-weight: bold; mso-ansi-language: EN-US"> The objectives of this study were the gene amplification, cloning, expression, purification and</SPAN><SPAN lang=EN-US style="mso-bidi-font-weight: bold; mso-ansi-language: EN-US"><FONT size=4> </FONT></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-bidi-font-weight: bold; mso-ansi-language: EN-US">characterized of the probable</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-ansi-language: EN-US"> GMPS from <I style="mso-bidi-font-style: normal">M. tuberculosis</I>. Oligonucleotides complementary to the <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /><st1:metricconverter w:st="on" ProductID="5¡¯">5'</st1:metricconverter> and <st1:metricconverter w:st="on" ProductID="3¡¯">3'</st1:metricconverter>ends of the <I style="mso-bidi-font-style: normal">Rv3396c</I> coding sequence were designed and used to amplify the <I style="mso-bidi-font-style: normal">guaA</I> gene from <I style="mso-bidi-font-style: normal">M. tuberculosis</I> H37Rv genomic DNA. The PCR product (1578 bp) was gel-purified and cloned into the pCR-Blunt vector. Then, it was cleaved with <I style="mso-bidi-font-style: normal">Nde</I>I and <I style="mso-bidi-font-style: normal">BamH</I>I restriction enzymes and subcloned into the pET-23a(+) expression vector. Automatic DNA sequencing of the cloned fragment confirmed both identity and absence of gene mutations. Different protein expression conditions and <I style="mso-bidi-font-style: normal">Escherichia coli</I> host strains were tested for production of <I style="mso-bidi-font-style: normal">M. tuberculosis</I> GMPS. After introducing the recombinant expression plasmid into <I style="mso-bidi-font-style: normal">E. coli</I>, 1.5 ml of culture were collected at specific time points (3, 6, 9, 24 and 48 hours of incubation), centrifuged and cells were disrupted by sonication. Soluble and insoluble fractions were analyzed by SDS-PAGE and Coomassie Brilliant Blue staining. The <I style="mso-bidi-font-style: normal">M. tuberculosis</I> enzyme was successfully expressed in the soluble fraction of <I style="mso-bidi-font-style: normal">E. coli</I> C41(DE3) grown at 37ºC in LB medium containing <st1:metricconverter w:st="on" ProductID="1 mM">1 mM</st1:metricconverter> of isopropyl-<FONT face=Symbol>b</FONT></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-ansi-language: EN-US">-D-thiogalactopiranoside. The next steps of this work will be the purification, </SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-bidi-font-size: 10.0pt; mso-ansi-language: EN-US">biochemical and kinetic characterization of GMPS, aiming at developing new drugs to treat TB.</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 150%; mso-ansi-language: EN-US"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></font></p><br><b>Palavras-chave: </b>&nbsp;GMP synthase, Mycobacterium tuberculosis, Nucleotide metabolism</td></tr></table></tr></td></table></body></html>